Patient Comparison

Limb Salvage vs Amputation

For most bone and soft-tissue tumours today, the choice is no longer "lose the limb or lose your life". Both options can offer the same chance of cure — this guide explains when each is chosen and what to expect.

Limb salvage surgery

The tumour is removed with a wide, clear margin and the limb is rebuilt using an endoprosthesis, bone graft, or biological reconstruction. Now possible for over 90% of extremity sarcomas.

Amputation

The affected portion of the limb is removed and rehabilitated with a modern external prosthesis. It remains the right choice when salvage cannot safely clear the tumour or restore useful function.

Side by side

How the two options compare

Aspect	Limb salvage	Amputation
What it means	The tumour is removed and the limb is reconstructed with a prosthesis, bone graft, or biological technique.	The affected part of the limb is removed. An external prosthesis is fitted after healing.
Best suited for	Tumours that can be removed with clear margins while preserving major nerves, vessels and enough functional muscle.	Very large tumours, extensive neurovascular involvement, pathological fracture with contamination, failed reconstruction, or infection.
Cancer control	Equivalent survival to amputation when clear margins are achieved.	Equivalent survival when limb salvage is not oncologically safe — the choice does not compromise cure.
Function	Retains the native limb; function depends on which muscles and joints are reconstructed.	Function relies on prosthetic fit and rehabilitation; modern prostheses give good mobility for many patients.
Recovery time	Longer initial recovery; multiple follow-up procedures may be needed over years.	Faster initial healing; prosthetic training begins once the residual limb has healed.
Long-term care	Prosthesis or graft may need revision surgery; infection and mechanical wear are known risks.	External prosthesis needs periodic replacement; skin and residual-limb care is lifelong.

When limb salvage is preferred

Tumour can be removed with a safe, wide margin.
Major nerves and blood vessels can be preserved.
Enough muscle remains for a functional limb.
Response to chemotherapy has downsized the tumour.
Reconstruction is technically feasible.

When amputation may be safer

Tumour encases major nerves or blood vessels.
Extensive skin, muscle or joint destruction.
Pathological fracture with widespread contamination.
Infection or failure of a previous reconstruction.
A functional limb cannot realistically be restored.

Outcomes

What the evidence says

When either option is oncologically appropriate, long-term survival is the same. The choice is about function, complications and quality of life — not cure.

Survival

No survival advantage for one option over the other when clear margins can be achieved by either.

Function

Salvage generally provides better limb function; well-fitted modern prostheses can also give strong outcomes after amputation.

Complications

Salvage carries higher rates of revision surgery, infection and mechanical wear; amputation has lower re-operation rates.

Learn more about the surgery

Limb Salvage Surgery Tumour Endoprosthesis Biological Reconstruction Rotationplasty

Patient Stories

How limb salvage changes lives

Real patients, real reconstructions — short clips showing what limb salvage can achieve even in the most challenging tumours.

Limb salvage in action — patient story

Reconstruction after tumour removal

Function restored — walking again

Complex case, saved limb

What the evidence shows

Frequently asked questions

A plain-language walk-through of what published real-world data actually shows on survival, recurrence, function and quality of life.

What is the difference between limb salvage surgery and amputation?

Limb salvage surgery (LSS) removes the tumour with a cuff of healthy tissue around it while reconstructing the limb — using bone grafts, metal endoprostheses, or vascularised tissue transfers — so the arm or leg is preserved and functional. Amputation removes the limb (or part of it) at a level above the tumour. Both aim for the same oncological goal: complete removal of the cancer with clear margins. The decision depends on tumour size, location, involvement of major nerves and blood vessels, response to chemotherapy, and the patient's overall fitness.

Does saving the limb come at the cost of survival?

No — real-world data consistently shows the opposite. A tertiary-care five-year follow-up study reported overall survival of 83.8% in the limb-salvage group versus 62.5% in the amputation group. A large SEER population study of over 2,800 patients with early-stage extremity bone cancer similarly found a survival advantage for limb salvage. A propensity-matched study of adolescents and young adults reported five-year survival of roughly 76.5% (limb salvage) vs 65.1% (amputation), and a pooled meta-analysis of osteosarcoma patients treated with neoadjuvant chemotherapy found nearly double the odds of five-year survival with limb salvage. Part of this gap reflects that amputation is often chosen for more advanced tumours — but across independent datasets, limb salvage, when oncologically appropriate, has not been shown to compromise survival.

Does keeping the limb increase the risk of local recurrence?

Some series show a modestly higher local recurrence rate after limb salvage, since amputation removes the entire compartment. However, a 2020 systematic review and meta-analysis found no significant difference in five-year disease-free survival between the two approaches. For soft-tissue sarcomas treated with wide margins and radiotherapy, local recurrence rates of 6–10% at five years are reported without amputation, and limb salvage is achievable in around 96% of appropriately selected extremity sarcoma patients.

How much better is function and quality of life after limb salvage?

Functional outcome scores consistently favour limb salvage. In one comparative study, mean scores were 88.4% for limb-salvage patients versus 79% for amputees, with better physical and emotional quality-of-life scores on standardised questionnaires (TESS, SF-36, QLQ-C30, MSTS). Gains are most pronounced in the lower limb, where preserved joints and native sensation offer real advantages over prosthetic mobility.

Is there a psychological advantage to keeping the limb?

This is more nuanced than commonly assumed. Long-term studies of cognitive function, mood, body image and adjustment have found no statistically significant difference in psychological outcomes between amputees and limb-salvage patients — both groups generally show good long-term adjustment. Limb salvage clearly benefits physical function, but a consistent psychological-outcome advantage has not been proven — reassuring for the minority of patients for whom amputation is the right oncological choice.

When is amputation still the right — or only — choice?

Amputation remains essential when a tumour has invaded major nerves or vessels that cannot be reconstructed, when the tumour is too large for a functional salvage, in certain local recurrences after failed limb salvage, in uncontrolled infection, or when the patient's overall condition makes a shorter, lower-risk operation the wiser path. In these carefully selected cases, amputation offers excellent local disease control — one series reported five-year local-recurrence-free survival of 84% — and remains a team decision made in the patient's best interest.

Does the same pattern hold for soft-tissue sarcoma of the arm or leg?

Yes. With modern combined treatment — wide surgical excision plus radiotherapy — amputation is needed in only a small minority of extremity soft-tissue sarcoma cases (historically as low as 4% in some large series), while achieving five-year survival of 58–67% and local recurrence rates of 6–10%. Even after a local recurrence, further limb-sparing salvage surgery is often still possible, with long-term local control rates of 42–67% in specialised centres.

The bottom line

In appropriately selected patients, real-world data from multiple independent cohorts — spanning paediatric and adult osteosarcoma, soft-tissue sarcoma and population-level cancer registries — shows that limb salvage surgery is not a compromise on cancer control. It offers comparable or better survival, comparable disease-free survival, and meaningfully better limb function and quality of life than amputation. Amputation remains a vital, correct choice for a defined subset of patients where tumour extent, anatomy or complications make it the safer or only path to cure.

Selected sources

Comparative Outcomes of Limb Salvage Surgery Versus Amputation in Osteosarcoma: A Five-Year Follow-Up Study From a Tertiary Care Center (PMC)
Limb-salvage surgery versus extremity amputation for early-stage bone cancer in the extremities: a population-based study — Frontiers in Surgery / PMC
Limb-salvage surgery offers better five-year survival than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy: systematic review and meta-analysis — ScienceDirect / PubMed
Amputation Versus Limb-Salvage Surgery as Treatments for Pediatric Bone Sarcoma: A Comparative Study of Survival, Function, and Quality of Life (PMC)
Amputation for Extremity Sarcoma: Indications and Outcomes (PMC)
Quality of Life Following Amputation or Limb Preservation in Patients with Lower Extremity Bone Sarcoma — Frontiers in Oncology / PMC

Talk to a specialist about your options

Every patient is different. A face-to-face discussion with an orthopaedic oncology surgeon is the best way to understand which option is right for you.

Book an appointment Contact the clinic

Medical disclaimer: This page is for general education and does not replace personalised medical advice. Decisions about limb salvage or amputation must be made with a qualified orthopaedic oncology team based on your individual diagnosis, imaging and overall health.